Journal of Substance Abuse Treatment
July 1, 2022
Patrick Köck, Katharina Froelich, Marc Walter et al.
68 citations
Iboga and its primary alkaloids, ibogaine and noribogaine, have been of interest to researchers and practitioners, mainly due to their putative efficacy in treating substance use disorders (SUDs). For many SUDs, still no effective pharmacotherapies exist. Distinct psychoactive and somatic effects of the iboga alkaloids set them apart from classic hallucinogens like LSD, mescaline, and...
Journal of Substance Abuse Treatment
May 8, 2021
Nina A Cooperman, Adam W. Hanley, Anna Kline et al.
Background: Chronic pain is highly prevalent among people in methadone maintenance treatment (MMT) for opioid use disorder and is known to be an important contributor to treatment discontinuation and opioid relapse. Mindfulness-Oriented Recovery Enhancement (MORE) is one of the few interventions developed and tested as an integrated treatment to simultaneously address both pain and illicit...
Journal of Substance Abuse Treatment
April 1, 2018
Jan Gryczynski, Robert Schwartz, Marc J Fishman et al.
Maladaptive responses to stress are thought to play a role in addiction and relapse. Transcendental Meditation (TM) is a popular meditation technique with promising clinical applications. This study sought to: (a) examine the feasibility of providing TM during AUD treatment; (b) compare outcomes for TM vs. treatment as usual (TAU); and (c) investigate the relationship between TM practice and...
Journal of Substance Abuse Treatment
July 1, 2008
Valerie Hoover, Douglas B. Marlowe, Nicholas S Patapis et al.
38 citations
This study determined the degree to which Salvia divinorum, a potent hallucinogenic drug that is legal in most U.S. jurisdictions, is being proffered for sale over the Internet and how it is being characterized on popular Web sites. Search results revealed that between one half and two thirds (58%) of the Web sites either offered to sell S. divinorum or linked to other Web sites offering to...
Journal of Substance Abuse Treatment
March 1, 2007
Traci Rieckmann, Marilyn Daley, Bret E Fuller et al.
75 citations
Attitudes, perceived social norms, and intentions were assessed for 376 counselors and 1,083 clients from outpatient, methadone, and residential drug treatment programs regarding four medications used to treat opiate dependence: methadone, buprenorphine, clonidine, and ibogaine. Attitudes, social norms, and intentions to use varied by treatment modality. Methadone clients and counselors had...
Journal of Substance Abuse Treatment
December 1, 2002
Evgeny Krupitsky, Andrey Burakov, Tatyana N. Romanova et al.
240 citations
Seventy detoxified heroin-addicted patients were randomly assigned to one of two groups receiving ketamine psychotherapy (KPT) involving two different doses of ketamine. The patients of the experimental group received existentially oriented psychotherapy in combination with a hallucinogenic ("psychedelic") dose of ketamine (2.0 mg/kg im). The patients of the control group received the same...
Journal of Substance Abuse Treatment
1994
S G Sheppard
162 citations
A naturally occurring substance, ibogaine, was taken by seven individuals who were addicted to opiates. Ibogaine, an alkaloid with psychotropic effects at doses of 200-300 mg and above, was taken in single doses of 700-1800 mg by the subjects in the study. At the end of the 24-38-hr psychoactive period induced by the drug at these doses, none of the subjects displayed significant opiate...
Journal of Substance Abuse Treatment
1991
John D. Mcpeake, Bruce P. Kennedy, Sharon M. Gordon
32 citations
Attaining altered states of consciousness is described as a basic human motive. The substance dependent population is distinguished from other populations because they pursue these states destructively by inappropriate use of alcohol and drugs. Despite a body of literature supporting the benefits of altered states of consciousness, alcohol and drug rehabilitation treatment programs fail to...